Cargando…
Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma
Osteosarcoma is the most common primary bone tumor in both humans and dogs. It is a highly metastatic cancer and therapy has not improved significantly since the inclusion of adjuvant chemotherapy into disease treatment strategies. Osteosarcoma is an immunogenic tumor, and thus development of immuno...
Autores principales: | Kisseberth, William C., Lee, Dean A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215197/ https://www.ncbi.nlm.nih.gov/pubmed/34164452 http://dx.doi.org/10.3389/fvets.2021.672361 |
Ejemplares similares
-
Natural Killer and T Cell Infiltration in Canine Osteosarcoma: Clinical Implications and Translational Relevance
por: Razmara, Aryana M., et al.
Publicado: (2021) -
Case Report: Metastatic Parosteal Osteosarcoma in a Dog
por: Samuels, Sarah K., et al.
Publicado: (2021) -
Recent Advances in the Discovery of Biomarkers for Canine Osteosarcoma
por: Luu, Anita K., et al.
Publicado: (2021) -
Canine osteosarcoma in comparative oncology: Molecular mechanisms through to treatment discovery
por: Simpson, Siobhan, et al.
Publicado: (2022) -
Editorial: Canine osteosarcoma as a model in comparative oncology: Advances and perspective
por: Romanucci, Mariarita, et al.
Publicado: (2023)